Grant Skrepnek to Managed Care Programs
This is a "connection" page, showing publications Grant Skrepnek has written about Managed Care Programs.
Connection Strength
0.611
-
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Curr Med Res Opin. 2005 Feb; 21(2):261-70.
Score: 0.243
-
Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S1-53.
Score: 0.105
-
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
Score: 0.105
-
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother. 2005 Nov; 39(11):1785-91.
Score: 0.064
-
Regression methods in the empiric analysis of health care data. J Manag Care Pharm. 2005 Apr; 11(3):240-51.
Score: 0.061
-
State Medicaid Programs Bring Managed Care Tenets to Fee for Service. J Manag Care Spec Pharm. 2016 Feb; 22(2):145-8.
Score: 0.032